{
    "clinical_study": {
        "@rank": "93935", 
        "arm_group": [
            {
                "arm_group_label": "Multiple Sclerosis", 
                "description": "Subjects who have been diagnosed with clinically definite or probable multiple sclerosis as defined and recorded by board certified neurologist."
            }, 
            {
                "arm_group_label": "Healthy controls", 
                "description": "Adults age 18 and older who have not been diagnosed with any neurological, endocrine, or other chronic health condition. They must also be free of any recent acute illness that can impact inflammation/clotting."
            }
        ], 
        "biospec_descr": {
            "textblock": "Six (6) whole blood vials of 10ml each will be collected from each subject. Three (3) will\n      be stored for future use. Three will be used immediately for coagulation analysis using\n      Sonoclot."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Recent research in multiple sclerosis (MS) have suggested that altered coagulation and\n      vascular inflammation may play a role in pathophysiology of MS. Sonoclot is viscoelastic\n      method of analyzing clot formation. This instrument will be used to compare coagulation in\n      individuals with MS to healthy controls.  A 24-hour dietary recall and food frequency\n      questionnaire will help determine whether coagulation is modified by fish consumption."
        }, 
        "brief_title": "Evaluation of Coagulation in Multiple Sclerosis", 
        "condition": "Multiple Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Multiple Sclerosis", 
                "Sclerosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "This case-control study will recruit individuals with a diagnosis of MS and healthy\n      controls.  Individuals will be asked to come to Bastyr Clinical Research Center for a single\n      study visit, at which time dietary intake, current medications and supplements, other\n      medical diagnoses, and coagulation will be evaluated."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of clinically probable of clinically definite multiple sclerosis made by\n             board certified neurologist. Subject must be willing to release medical information\n             regarding diagnosis\n\n          -  Controls must consider themselves healthy and be free of any neurological,\n             autoimmune, endocrine or other chronic disease. Must also be free of any recent acute\n             illness/injury that can influence inflammatory activity.\n\n          -  Individuals must be 18 or older\n\n        Exclusion Criteria:\n\n          -  Diagnosis of coagulation defect\n\n          -  Use of anticoagulants (eg. warfarin, coumadin) or Aspirin within 30 days of entry.\n\n          -  NSAID within 7 days of entry (dietary intake of fish oil or tumeric is acceptable)\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Study population will be sixty (60) individuals with diagnosed or probable multiple\n        sclerosis, verified by board certified neurologist, and forty (40) age and sex matched\n        healthy controls."
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01711255", 
            "org_study_id": "BU-12A-1323"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Multiple sclerosis", 
            "Coagulation", 
            "Alternative Medicine", 
            "Clotting", 
            "Complementary Medicine", 
            "Inflammation"
        ], 
        "lastchanged_date": "October 22, 2012", 
        "link": {
            "description": "Related info", 
            "url": "http://www.bastyr.edu/research/clinical-research-center/integrative-neuroscience-research"
        }, 
        "location": {
            "contact": {
                "email": "neuroresearch@bastyr.edu", 
                "last_name": "Laurie K Mischley, ND", 
                "phone": "425-602-3306"
            }, 
            "contact_backup": {
                "email": "mvespignani@bastyr.edu", 
                "last_name": "Marco F Vespignani, ND", 
                "phone": "425-602-3309"
            }, 
            "facility": {
                "address": {
                    "city": "Kenmore", 
                    "country": "United States", 
                    "state": "Washington", 
                    "zip": "98028"
                }, 
                "name": "Bastyr University Clinical Research Center"
            }, 
            "investigator": {
                "last_name": "Laurie K Mischley, ND", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "A Cross-Sectional Study of Coagulation in Multiple Sclerosis", 
        "overall_contact": {
            "email": "lmischley@bastyr.edu", 
            "last_name": "Laurie K Mischley, ND", 
            "phone": "425 602-3306"
        }, 
        "overall_official": {
            "affiliation": "Bastyr University - Clinical Research Center", 
            "last_name": "Laurie K Mischley, ND", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The Sonoclot Coagulation Spectrum represents a combination of coagulation parameters, including activated clotting time, clot rate, time to peak, and peak amplitude.  The mean value of all contributing parameters will be compared between cases and controls.", 
            "measure": "Sonoclot Coagulation Spectrum (Sonoclot Signature)", 
            "safety_issue": "No", 
            "time_frame": "Day 1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01711255"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The ASA24, in combination with a medication history, will be used to evaluate whether omega-3 fatty acid intake is associated with reduced rates of coagulation in either cases or controls.", 
            "measure": "ASA24 omega-3 fatty acid intake", 
            "safety_issue": "No", 
            "time_frame": "24 hour recall (24 hours prior to study visit)"
        }, 
        "source": "Bastyr University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bastyr University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "October 2012"
    }
}